These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2455908

  • 1. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW.
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [Abstract] [Full Text] [Related]

  • 2. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH, Siddall JK, Newling DW, Robinson MR.
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract] [Full Text] [Related]

  • 3. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM, Bogdanowicz JF, Oosterom R, Schröder FH.
    Ned Tijdschr Geneeskd; 1990 Aug 18; 134(33):1596-600. PubMed ID: 1697651
    [Abstract] [Full Text] [Related]

  • 4. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
    Killian CS, Emrich LJ, Vargas FP, Yang N, Wang MC, Priore RL, Murphy GP, Chu TM.
    J Natl Cancer Inst; 1986 Feb 18; 76(2):179-85. PubMed ID: 2418245
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer-associated markers.
    Chu TM.
    Immunol Ser; 1990 Feb 18; 53():339-56. PubMed ID: 1713065
    [Abstract] [Full Text] [Related]

  • 6. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
    Shinoda I.
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov 20; 25(11):2627-39. PubMed ID: 1703555
    [Abstract] [Full Text] [Related]

  • 7. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
    Tarle M.
    Anticancer Res; 1988 Nov 20; 8(4):569-72. PubMed ID: 2460018
    [Abstract] [Full Text] [Related]

  • 8. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Nov 20; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 9. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 Nov 20; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 10. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P, Rymer JC, Chopin D, Kouyoudjian JC, Abbou CC, Auvert J.
    Ann Urol (Paris); 1988 Nov 20; 22(3):199-205. PubMed ID: 2456713
    [Abstract] [Full Text] [Related]

  • 11. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S, Akakura K, Fuse H, Shimazaki J.
    Hinyokika Kiyo; 1988 Apr 20; 34(4):636-42. PubMed ID: 2456678
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma].
    Dutkiewicz S, Stepień K, Witeska A.
    Wiad Lek; 1992 Oct 20; 45(19-20):750-3. PubMed ID: 1284261
    [Abstract] [Full Text] [Related]

  • 13. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
    Mortarelli EA.
    Ann Clin Lab Sci; 1992 Oct 20; 22(4):201-6. PubMed ID: 1380223
    [Abstract] [Full Text] [Related]

  • 14. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H, Hørder M.
    Scand J Urol Nephrol Suppl; 1988 Oct 20; 107():65-70. PubMed ID: 2453920
    [Abstract] [Full Text] [Related]

  • 15. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K, Tanaka M, Kitagawa N, Kotake T, Yanagi S, Ito H.
    Hinyokika Kiyo; 1989 Jun 20; 35(6):987-91. PubMed ID: 2478006
    [Abstract] [Full Text] [Related]

  • 16. [Metastasis and markers].
    Trinchieri A, Rovera F, Longo G, Del Nero A, Zanetti G, Austoni E.
    Arch Ital Urol Nefrol Androl; 1992 Mar 20; 64(1):27-30. PubMed ID: 1373913
    [Abstract] [Full Text] [Related]

  • 17. [Relationship between reactivation and tumor markers in prostatic cancer].
    Fuse H, Umeda K, Kazama T, Sakamoto M, Sakai T, Fujishiro Y, Mizuno I, Katayama T.
    Hinyokika Kiyo; 1991 Jan 20; 37(1):39-43. PubMed ID: 1707217
    [Abstract] [Full Text] [Related]

  • 18. Prostate specific antigen. Experimental and clinical observations.
    Huber PR, Schnell Y, Hering F, Rutishauser G.
    Scand J Urol Nephrol Suppl; 1987 Jan 20; 104():33-9. PubMed ID: 2449722
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC, Kiwamoto H, Nishioka T, Tsujihashi H, Mitsubayashi S, Matsuura T, Akiyama T, Kurita T, Miyamoto T.
    Hinyokika Kiyo; 1987 Jun 20; 33(6):883-8. PubMed ID: 2445188
    [Abstract] [Full Text] [Related]

  • 20. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI.
    Urol Clin North Am; 1993 Nov 20; 20(4):757-70. PubMed ID: 7505984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.